Literature DB >> 35853997

Mechanisms and consequences of endothelial cell senescence.

Samuel I Bloom1, Md Torikul Islam1, Lisa A Lesniewski1,2,3, Anthony J Donato4,5,6,7.   

Abstract

Endothelial cells are located at the crucial interface between circulating blood and semi-solid tissues and have many important roles in maintaining systemic physiological function. The vascular endothelium is particularly susceptible to pathogenic stimuli that activate tumour suppressor pathways leading to cellular senescence. We now understand that senescent endothelial cells are highly active, secretory and pro-inflammatory, and have an aberrant morphological phenotype. Moreover, endothelial senescence has been identified as an important contributor to various cardiovascular and metabolic diseases. In this Review, we discuss the consequences of endothelial cell exposure to damaging stimuli (haemodynamic forces and circulating and endothelial-derived factors) and the cellular and molecular mechanisms that induce endothelial cell senescence. We also discuss how endothelial cell senescence causes arterial dysfunction and contributes to clinical cardiovascular diseases and metabolic disorders. Finally, we summarize the latest evidence on the effect of eliminating senescent endothelial cells (senolysis) and identify important remaining questions to be addressed in future studies.
© 2022. Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35853997     DOI: 10.1038/s41569-022-00739-0

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   49.421


  192 in total

Review 1.  Cellular senescence: when bad things happen to good cells.

Authors:  Judith Campisi; Fabrizio d'Adda di Fagagna
Journal:  Nat Rev Mol Cell Biol       Date:  2007-09       Impact factor: 94.444

2.  Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells.

Authors:  Toyohiko Yokoi; Keisuke Fukuo; Osamu Yasuda; Mizuo Hotta; Junichi Miyazaki; Yukihiro Takemura; Hidenobu Kawamoto; Hidenori Ichijo; Toshio Ogihara
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

3.  Send in the senolytics.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2020-12       Impact factor: 54.908

4.  Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes.

Authors:  Toshio Hayashi; Hitoshi Kotani; Tomoe Yamaguchi; Kumiko Taguchi; Mayu Iida; Koichiro Ina; Morihiko Maeda; Masafumi Kuzuya; Yuichi Hattori; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-07       Impact factor: 11.205

5.  Strategies for Targeting Senescent Cells in Human Disease.

Authors:  Nathan S Gasek; George A Kuchel; James L Kirkland; Ming Xu
Journal:  Nat Aging       Date:  2021-10-07

6.  Senolytic drugs: Beyond the promise and the hype.

Authors:  Diana Jurk; João F Passos
Journal:  Mech Ageing Dev       Date:  2022-01-12       Impact factor: 5.498

7.  Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan.

Authors:  Laurent Grosse; Nicole Wagner; Alexander Emelyanov; Clement Molina; Sandra Lacas-Gervais; Kay-Dietrich Wagner; Dmitry V Bulavin
Journal:  Cell Metab       Date:  2020-06-01       Impact factor: 27.287

8.  Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice.

Authors:  Matthew J Yousefzadeh; Jing Zhao; Christina Bukata; Erin A Wade; Sara J McGowan; Luise A Angelini; Michael P Bank; Aditi U Gurkar; Collin A McGuckian; Mariah F Calubag; Jonathan I Kato; Christin E Burd; Paul D Robbins; Laura J Niedernhofer
Journal:  Aging Cell       Date:  2020-01-25       Impact factor: 9.304

9.  Single-cell RNA sequencing identifies senescent cerebromicrovascular endothelial cells in the aged mouse brain.

Authors:  Tamas Kiss; Ádám Nyúl-Tóth; Priya Balasubramanian; Stefano Tarantini; Chetan Ahire; Jordan DelFavero; Andriy Yabluchanskiy; Tamas Csipo; Eszter Farkas; Graham Wiley; Lori Garman; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2020-03-31       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.